Nicholas Vahanian

Biography

 Nicholas Vahanian, MD, was appointed to the Board of Directors in November 2015. Dr Vahanian has served as president and chief medical officer of NewLink Genetics since 2009. He led the algenpantucel-L development program, including the IMPRESS trial. Dr Vahanian began his research career at the National Cancer Institute and continued on to the National Center for Human Genome Research Institute. Dr Vahanian holds a BS in biology from Virginia Commonwealth University in Richmond, Virginia, and an MBA from the University of Notre Dame in Notre Dame, Indiana. He attended St. Bartholomew's and Royal London Hospital Medical College where he earned his medical degree, and completed a fellowship in molecular oncology at the John Stoddard Cancer Research Institute in Urbandale, Iowa.

Research Interest

 Genetics